T. Rowe Price Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,325,491
| Closed | -$5.42M | – | 660 |
|
|
2024
Q2 | $5.42M | Sell |
1,325,491
-1,993,595
| -60% | -$8.15M | ﹤0.01% | 571 |
|
|
2024
Q1 | $52.3M | Buy |
3,319,086
+977,303
| +42% | +$15.4M | 0.03% | 389 |
|
|
2023
Q4 | $35.5M | Buy |
2,341,783
+369,299
| +19% | +$5.6M | 0.02% | 434 |
|
|
2023
Q3 | $39.6M | Sell |
1,972,484
-26,870
| -1% | -$539K | 0.03% | 396 |
|
|
2023
Q2 | $56.4M | Sell |
1,999,354
-11,055
| -0.5% | -$312K | 0.04% | 362 |
|
|
2023
Q1 | $34.6M | Sell |
2,010,409
-200,033
| -9% | -$3.44M | 0.02% | 411 |
|
|
2022
Q4 | $44.5M | Buy |
2,210,442
+1,773
| +0.1% | +$35.7K | 0.03% | 369 |
|
|
2022
Q3 | $47.8M | Buy |
+2,208,669
| New | +$47.8M | 0.04% | 352 |
|